Navigation Links
Adaptogenic Properties of Tahitian Noni Bioactive Beverages Revealed
Date:4/2/2010

dth="10"> 
  • Supports the immune system
  • Protects DNA
  • Promotes joint health
  • Increases energy & endurance
  • Helps maintain healthy circulatory system
  • Helps maintain healthy HDL cholesterol

John Wadsworth, president of Tahitian Noni explained, “Noni is different from all other superfruits like mangosteen, açaí, or gac, because it contains iridoids and other bioactive compounds, and has now been proven to be a world-class adaptogen.”

About the Company
Tahitian Noni International is a global, research-driven bioactive products company that was the first to introduce the health benefits of the noni plant—a bioactive-rich, adaptogenic plant, containing iridoid compounds—to the world outside of Tahiti. Tahitian Noni International is the leader in the discovery, development, manufacturing, and marketing of noni-based bioactive products including beverages, beauty, and weight loss lines.Tahitian Noni International has a presence in over 70 markets worldwide, and is the world-wide leader in bioactive beverages.

###

Read the full story at http://www.prweb.com/releases/iridoids/bioactive_products/prweb3826764.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. Tahitian Noni Bioactive Beverages™ Are Adaptogenic
2. New insight into selective binding properties of infectious HIV
3. New Study Reveals Pistachios Have Anti-Inflammatory Properties
4. Nationwide Health Properties, Inc. Announces the Redemption of All Outstanding Shares of 7.75% Series B Cumulative Convertible Preferred Stock
5. Garden-Grown Rhubarb May Have Anti-Cancer Properties
6. Forest City Announces Joint Venture with Health Care REIT for University Park Life Science Properties
7. Ensemble Healthcare Properties Purchases North Valley Medical Plaza
8. Tahitian Noni International Leaves the Superfruits Behind
9. Tahitian Noni Bioactive Beverages™ Contain Iridoids
10. Iridoids in Tahitian Noni Bioactive Beverages™ are Found to be Extremely Stable
11. Five New Tahitian Noni Bioactive Beverages™ Announced
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Adaptogenic Properties of Tahitian Noni Bioactive Beverages Revealed
(Date:8/3/2015)... PA (PRWEB) , ... August 03, 2015 , ... ... Africa , Infectious diseases researchers from the University of Pittsburgh School of Medicine ... rollout of HIV prevention drugs in sub-Saharan Africa. , A cooperative agreement ...
(Date:8/3/2015)... ... August 03, 2015 , ... Novation, the nation’s ... offer pharmacogenetic lab testing and precision medicine solutions that can help pharmacists and ... Annually, more than 8.6 million adverse drug events are reported in the U.S. ...
(Date:8/3/2015)... ... 2015 , ... Catalent Pharma Solutions, the leading global provider ... products, today welcomed the announcement by OPKO Health that the US Food and ... treatment for chronic kidney disease (CKD) and vitamin D insufficiency, which uses Catalent’s ...
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... Dental ... to help patients in need. Most people know that general health emergencies, such as ... a fewer amount of people know where to turn to during a dental emergency. ...
(Date:8/3/2015)... Orlando, FL (PRWEB) , ... August 03, 2015 ... ... upgrade to date of its industry-defining contract lifecycle management solution, as well as ... features designed to increase the speed and ease of contract management tasks as ...
Breaking Medicine News(10 mins):Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 2Health News:Los Angeles Dental Practice, Sunset Plaza Dental, Now Offers Emergency Dental Services 3Health News:Novatus Unveils Milestone Software Release 2
... help lower the risk of pre-eclampsia, doctors say. ,Their ... high-risk women can reduce the risk of perinatal death ... of pre-eclampsia or who had chronic hypertension, diabetes or ... mg to 150 mg) //of aspirin were less likely ...
... reduce their risk of heart attacks, shows a new ... minimize cardiovascular disease in people with high cholesterol, and ... cholesterol levels who have other conditions that put them ... have a significantly //higher risk of heart disease. The ...
... Vitamin D could hold a clue to more effective breast ... of Dartmouth researchers in a report in the June issue ... involved the treatment of breast cancer tumors in mice, adds ... vitamin D known as EB1089 may yield some powerful anti-cancer ...
... serve as a new target for drugs designed to treat ... a homolog of a protein found in the fruit fly ... Institute for Biological Studies in La Jolla, California, and colleagues ... search to identify proteins that modulate the activity of Akt, ...
... of hot flashes in menopausal women, a drug company-funded ... the drug's effectiveness was limited. Alternative treatments to hormone ... night sweats and memory and sleep problems will be ... //hormone therapy increases women's risks of cancer, strokes and ...
... powerful endorsement to new strategic directions for child and ... reduce childhood deaths and long term disability. It also ... year. ,Last year, the number of children and adolescents ... deaths from AIDS, tuberculosis and malaria combined.// In 2000 ...
Cached Medicine News:Health News:Hope for 11 million children facing death from illnesses 2
(Date:8/3/2015)... 2015 VWR (NASDAQ: VWR ), ... announces the redesign of its global website, www.vwr.com , ... visiting the new site, guests will enjoy enhanced content on ... images.  Each country site now includes: , ... menu; and , the ability to search by discipline/industry. ...
(Date:8/3/2015)... , August 3, 2015 ... Media Group LLC, PIV757417 The following release: "Biotech ... Orphan Drug Products & Treatments for Critical-Care Patients ... Distribution time: 3 Aug 2015 12:30 GMT ... companies, military surgical research and top-tier universities for ...
(Date:8/3/2015)... , Aug. 3, 2015  Charleston Laboratories, Inc., ... its second clinical development program with a Phase ... CL-H1T contains fast-dissolving promethazine and ... as a treatment for migraine headache pain and ... "Many patients with migraine headaches also suffer from ...
Breaking Medicine Technology:VWR's New Website Redesign Provides Improved Functionality for Customers 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 2/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 3/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 4/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 5/OFF HOLD OFF HOLD OFF HOLD -- FN Media Group LLC/ 6Charleston Laboratories, Inc. Initiates Patient Enrollment in a Phase 1 Study of Charleston's Second Product, CL-H1T 2
... May Include Direct Activity in the Brain , ... help reduce neurodegeneration and enhance repair of the,CNS ... from the six-month multiple,sclerosis Phase II clinical study ... was significantly lower in the,FTY720 groups compared to ...
... May 4, at 9:00 a.m.,Eastern Time to Discuss ... Inc. today announced that new data from the ... the Company's,six-month Phase 2 efficacy study of Dimebon ... patients on,all five efficacy endpoints studied. , The ...
Cached Medicine Technology:Data to be presented at AAN Meeting -Study results of drug,candidate for MS 2Data to be presented at AAN Meeting -Study results of drug,candidate for MS 3Data to be presented at AAN Meeting -Study results of drug,candidate for MS 4Data to be presented at AAN Meeting -Study results of drug,candidate for MS 5Data to be presented at AAN Meeting -Study results of drug,candidate for MS 6Data to be presented at AAN Meeting -Study results of drug,candidate for MS 7Data to be presented at AAN Meeting -Study results of drug,candidate for MS 8Data to be presented at AAN Meeting -Study results of drug,candidate for MS 9Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 2Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 3Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 4Medivation Announces Presentation of New Subset Analyses From,Dimebon Phase 2 Alzheimer's Disease Trial at American Academy of,Neurology Annual Meeting 5
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: